Suchergebnisse - "Fajgenbaum, David C."

PubPharm (8)

1

Transcriptome and unique cytokine microenvironment of Castleman disease

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022

von Wing, A. | Xu, J. | Meng, W. | +12

2

Is severe COVID-19 a cytokine storm syndrome : a hyperinflammatory debate

enthalten in: Current opinion in rheumatology | 2021

von Mehta, P. | Fajgenbaum, D.

3

enthalten in: The New England journal of medicine | 2020

von Fajgenbaum, D. | June, C.

CommentIn: N Engl J Med. 2021 Apr 22;384(16):e59. - PMID 33882214

4

Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

enthalten in: JCI insight | 2020

von Pai, R. | Japp, A. | Gonzalez, M. | +12

5

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

6

Castleman Disease Pathogenesis

enthalten in: Hematology/oncology clinics of North America | 2018

von Fajgenbaum, D. | Shilling, D.

7

TAFRO syndrome : New subtype of idiopathic multicentric Castleman disease

enthalten in: Bosnian journal of basic medical sciences | 2017

von Srkalovic, G. | Marijanovic, I. | Srkalovic, M. | +1

8

HHV-8-negative, idiopathic multicentric Castleman disease : novel insights into biology, pathogenesis, and therapy

enthalten in: Blood | 2014

von Fajgenbaum, D. | van Rhee, F. | Nabel, C.

1
[1]